958
Views
19
CrossRef citations to date
0
Altmetric
Research Paper

A novel vaccine p846 encoding Rv3615c, Mtb10.4, and Rv2660c elicits robust immune response and alleviates lung injury induced by Mycobacterium infection

, &
Pages 378-390 | Received 18 Sep 2013, Accepted 07 Nov 2013, Published online: 26 Nov 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Farzad Khademi, Mohammad Derakhshan, Arshid Yousefi-Avarvand, Mohsen Tafaghodi & Saman Soleimanpour. (2018) Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?. Expert Review of Vaccines 17:1, pages 31-44.
Read now
Ming Zhang, Chunsheng Dong & Sidong Xiong. (2017) Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection. Human Vaccines & Immunotherapeutics 13:4, pages 816-822.
Read now
Xindong Teng, Maopeng Tian, Jianrong Li, Songwei Tan, Xuefeng Yuan, Qi Yu, Yukai Jing, Zhiping Zhang, Tingting Yue, Lei Zhou & Xionglin Fan. (2015) Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine. Human Vaccines & Immunotherapeutics 11:6, pages 1456-1464.
Read now

Articles from other publishers (15)

Farnaz Khodabakhsh, Davoud Nouri Inanlou, Vahid Asgary, Razieh Bigdeli, Samane Sadat Mirmoosa, Ramin Farhoudi & Reza Ahangari Cohan. (2023) Cerium Nanoparticles Can Enhance Humoral and Cellular Immune Responses of Multi-epitope Vaccine Candidates. BioNanoScience.
Crossref
Omid Salemi, Zahra Noormohammadi, Fariborz Bahrami, Seyed Davar Siadat & Soheila Ajdary. (2023) Evaluation of the Immunogenicity of Recombinant Espb, Espc Proteins from Mycobacterium Tuberculosis and the Fusion Espc/Espb Protein in BALB/C Mice. Reports of Biochemistry and Molecular Biology 11:4, pages 590-598.
Crossref
Shaista Arif, Mohsina Akhter, Aasia Khaliq & Muhammad Waheed Akhtar. (2022) Fusion peptide constructs from antigens of M. tuberculosis producing high T-cell mediated immune response. PLOS ONE 17:9, pages e0271126.
Crossref
Saman Soleimanpour, Atieh Yaghoubi, Fereshteh Sadat Seddighinia & S.A. Rahim Rezaee. (2022) A century of attempts to develop an effective tuberculosis vaccine: Why they failed?. International Immunopharmacology 109, pages 108791.
Crossref
Xiufen Du, Daquan Tan, Yang Gong, Yifan Zhang, Jiangyuan Han, Wei Lv, Tao Xie, Pu He, Zongjie Hou, Kun Xu, Jiying Tan & Bingdong Zhu. (2022) A new poly(I:C)-decorated PLGA-PEG nanoparticle promotes Mycobacterium tuberculosis fusion protein to induce comprehensive immune responses in mice intranasally. Microbial Pathogenesis 162, pages 105335.
Crossref
Masoud Keikha, Majid Eslami, Bahman Yousefi & Mohsen Karbalaei. (2020) Overview of multistage subunit tuberculosis vaccines: advantages and challenges. Reviews in Medical Microbiology 31:3, pages 144-149.
Crossref
Yingying Chen, Jia-ni Xiao, Yong Li, Yang-jiong Xiao, Yan-qing Xiong, Ying Liu, Shu-jun Wang, Ping Ji, Guo-ping Zhao, Hao Shen, Shui-hua Lu, Xiao-yong Fan & Ying Wang. (2019) Mycobacterial Lipoprotein Z Triggers Efficient Innate and Adaptive Immunity for Protection Against Mycobacterium tuberculosis Infection. Frontiers in Immunology 9.
Crossref
Jiangping Li, Jun Zhao, Juan Shen, Changyou Wu & Jie Liu. (2019) Intranasal immunization with Mycobacterium tuberculosis Rv3615c induces sustained adaptive CD4 + T-cell and antibody responses in the respiratory tract . Journal of Cellular and Molecular Medicine 23:1, pages 596-609.
Crossref
Farzad Khademi, Ramezan Ali Taheri, Amir Abbas Momtazi-Borojeni, Gholamreza Farnoosh, Thomas P. Johnston & Amirhossein Sahebkar. 2018. Reviews of Physiology, Biochemistry and Pharmacology, Vol. 175. Reviews of Physiology, Biochemistry and Pharmacology, Vol. 175 47 69 .
Shuguang Tan, Nan Lin, Mingxiang Huang, Qing Wang, Yunhong Tan, Bingxi Li, Ning Zhang, Tianling Guo, Yingbin Cui, Xinchao Chen, Dongping Wang, Jue Wang, Haixia Xiao, William J. Liu, Jinghua Yan, Catherine W.-H. Zhang, Cui Hua Liu, Kanglin Wan & George F. Gao. (2017) CTL immunogenicity of Rv3615c antigen and diagnostic performances of an ESAT-6/CFP-10/Rv3615c antigen cocktail for Mycobacterium tuberculosis infection. Tuberculosis 107, pages 5-12.
Crossref
Jiangping Li, Juan Shen, Suihua Lao, Xiaomin Li, Jie Liu & Changyou Wu. (2017) Mycobacterium tuberculosis Rv3615c is a highly immunodominant antigen and specifically induces potent Th1-type immune responses in tuberculosis pleurisy . Clinical Science 131:15, pages 1859-1876.
Crossref
Gen Li, Feng Li, Hui-Min Zhao, Han-Li Wen, Hai-Cong Li, Chun-Ling Li, Ping Ji, Peng Xu, Kang Wu, Zhi-Dong Hu, Shui-Hua Lu, Douglas B. Lowrie, Jian-Xin Lv & Xiao-Yong Fan. (2017) Evaluation of a New IFN-γ Release Assay for Rapid Diagnosis of Active Tuberculosis in a High-Incidence Setting. Frontiers in Cellular and Infection Microbiology 7.
Crossref
Ming Zhang, Chunsheng Dong & Sidong Xiong. (2017) Vesicular Stomatitis Virus-Vectored Multi-Antigen Tuberculosis Vaccine Limits Bacterial Proliferation in Mice following a Single Intranasal Dose. Frontiers in Cellular and Infection Microbiology 7.
Crossref
Manli Wu, Min Li, Yan Yue & Wei Xu. (2016) DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine . Microbiology and Immunology 60:9, pages 634-645.
Crossref
Dafei Chai, Yan Yue, Wei Xu, Chunsheng Dong & Sidong Xiong. (2015) AIM2 co-immunization favors specific multifunctional CD8+ T cell induction and ameliorates coxsackievirus B3-induced chronic myocarditis. Antiviral Research 119, pages 68-77.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.